Resmetirom real-world data at The Liver Meeting 2026 show 12-month gains in liver stiffness, fat, and enzymes among patients ...

Most patients with CLL/SLL who discontinued a first-line BTK inhibitor did not start second-line therapy, and older age was ...

A systematic review and meta-analysis found GLP-1 RAs improved liver and metabolic markers in MASLD and MASH, but long-term ...

Most hospitalized COPD flare-ups aren't severe by bedside criteria, experts say, and a tiered testing bundle could guide ...

Senator Andy Kim (D, New Jersey) discusses plans to reverse Medicaid cuts and make caregiving a priority in the next Congress ...

Mailed fecal immunochemical test (FIT) outreach raised CRC screening at federally qualified health centers, but gains faded ...

Medigap Plan F enrollment has declined since it was closed to new beneficiaries in 2020. The percentage of individual Medigap ...

The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election require ...

No systemic scalp psoriasis therapy raised serious adverse event risk in a network meta-analysis; only apremilast increased discontinuation.

The University of Exeter’s David Halpin, MA, DPhil, discusses inhaler device selection, single vs multiple inhalers, and the pharmacist’s role in COPD.

Interleukin 33 (IL-33) biology differs from type 2 (T2) inflammation in ways that could allow biologic therapy to reach patients with chronic obstructive pulmonary disease (COPD) regardless of blood ...

Clinicians at Population Health Roundtables shared obesity care innovations, from pharmacist-led models to same-day liver screening ...